Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1794 1
1882 1
1883 4
1884 1
1887 1
1893 1
1899 2
1900 1
1901 1
1902 1
1906 1
1907 1
1908 3
1909 1
1910 1
1911 1
1912 2
1913 3
1916 1
1918 1
1922 2
1923 1
1925 1
1926 1
1927 1
1939 1
1945 4
1946 7
1947 10
1948 5
1949 6
1950 9
1951 10
1952 6
1953 6
1954 10
1955 9
1956 10
1957 2
1958 4
1959 9
1960 15
1961 4
1962 6
1963 8
1964 5
1965 13
1966 13
1967 17
1968 9
1969 9
1970 12
1971 10
1972 11
1973 8
1974 13
1975 11
1976 17
1977 6
1978 6
1979 14
1980 11
1981 7
1982 11
1983 13
1984 8
1985 12
1986 14
1987 9
1988 15
1989 17
1990 5
1991 18
1992 11
1993 22
1994 19
1995 15
1996 22
1997 13
1998 18
1999 17
2000 10
2001 25
2002 16
2003 31
2004 26
2005 25
2006 25
2007 22
2008 37
2009 57
2010 61
2011 57
2012 54
2013 53
2014 42
2015 44
2016 31
2017 40
2018 37
2019 53
2020 50
2021 78
2022 64
2023 56
2024 53

Text availability

Article attribute

Article type

Publication date

Search Results

1,545 results

Results by year

Filters applied: . Clear all
Page 1
Effects of Low FODMAP Diet on Symptoms, Fecal Microbiome, and Markers of Inflammation in Patients With Quiescent Inflammatory Bowel Disease in a Randomized Trial.
Cox SR, Lindsay JO, Fromentin S, Stagg AJ, McCarthy NE, Galleron N, Ibraim SB, Roume H, Levenez F, Pons N, Maziers N, Lomer MC, Ehrlich SD, Irving PM, Whelan K. Cox SR, et al. Gastroenterology. 2020 Jan;158(1):176-188.e7. doi: 10.1053/j.gastro.2019.09.024. Epub 2019 Oct 2. Gastroenterology. 2020. PMID: 31586453 Clinical Trial.
Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide.
Krewski D, Yokel RA, Nieboer E, Borchelt D, Cohen J, Harry J, Kacew S, Lindsay J, Mahfouz AM, Rondeau V. Krewski D, et al. J Toxicol Environ Health B Crit Rev. 2007;10 Suppl 1(Suppl 1):1-269. doi: 10.1080/10937400701597766. J Toxicol Environ Health B Crit Rev. 2007. PMID: 18085482 Free PMC article. Review. No abstract available.
Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study.
Kennedy NA, Heap GA, Green HD, Hamilton B, Bewshea C, Walker GJ, Thomas A, Nice R, Perry MH, Bouri S, Chanchlani N, Heerasing NM, Hendy P, Lin S, Gaya DR, Cummings JRF, Selinger CP, Lees CW, Hart AL, Parkes M, Sebastian S, Mansfield JC, Irving PM, Lindsay J, Russell RK, McDonald TJ, McGovern D, Goodhand JR, Ahmad T; UK Inflammatory Bowel Disease Pharmacogenetics Study Group. Kennedy NA, et al. Lancet Gastroenterol Hepatol. 2019 May;4(5):341-353. doi: 10.1016/S2468-1253(19)30012-3. Epub 2019 Feb 27. Lancet Gastroenterol Hepatol. 2019. PMID: 30824404
A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trial.
Noor NM, Lee JC, Bond S, Dowling F, Brezina B, Patel KV, Ahmad T, Banim PJ, Berrill JW, Cooney R, De La Revilla Negro J, de Silva S, Din S, Durai D, Gordon JN, Irving PM, Johnson M, Kent AJ, Kok KB, Moran GW, Mowat C, Patel P, Probert CS, Raine T, Saich R, Seward A, Sharpstone D, Smith MA, Subramanian S, Upponi SS, Wiles A, Williams HRT, van den Brink GR, Vermeire S, Jairath V, D'Haens GR, McKinney EF, Lyons PA, Lindsay JO, Kennedy NA, Smith KGC, Parkes M; PROFILE Study Group. Noor NM, et al. Lancet Gastroenterol Hepatol. 2024 May;9(5):415-427. doi: 10.1016/S2468-1253(24)00034-7. Epub 2024 Feb 22. Lancet Gastroenterol Hepatol. 2024. PMID: 38402895 Free PMC article. Clinical Trial.
Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial.
Richardson PG, Oriol A, Beksac M, Liberati AM, Galli M, Schjesvold F, Lindsay J, Weisel K, White D, Facon T, San Miguel J, Sunami K, O'Gorman P, Sonneveld P, Robak P, Semochkin S, Schey S, Yu X, Doerr T, Bensmaine A, Biyukov T, Peluso T, Zaki M, Anderson K, Dimopoulos M; OPTIMISMM trial investigators. Richardson PG, et al. Lancet Oncol. 2019 Jun;20(6):781-794. doi: 10.1016/S1470-2045(19)30152-4. Epub 2019 May 13. Lancet Oncol. 2019. PMID: 31097405 Clinical Trial.
Staphylococci: Evolving Genomes.
Lindsay JA. Lindsay JA. Microbiol Spectr. 2019 Nov;7(6):10.1128/microbiolspec.gpp3-0071-2019. doi: 10.1128/microbiolspec.GPP3-0071-2019. Microbiol Spectr. 2019. PMID: 31845645 Free PMC article. Review.
Personalized Implementation of Video Telehealth.
Lindsay JA, Day SC, Amspoker AB, Fletcher TL, Hogan J, Day G, Helm A, Stanley MA, Martin LA. Lindsay JA, et al. Psychiatr Clin North Am. 2019 Dec;42(4):563-574. doi: 10.1016/j.psc.2019.08.001. Epub 2019 Oct 1. Psychiatr Clin North Am. 2019. PMID: 31672207 Review.
A Diet Low in FODMAPs Reduces Symptoms in Patients With Irritable Bowel Syndrome and A Probiotic Restores Bifidobacterium Species: A Randomized Controlled Trial.
Staudacher HM, Lomer MCE, Farquharson FM, Louis P, Fava F, Franciosi E, Scholz M, Tuohy KM, Lindsay JO, Irving PM, Whelan K. Staudacher HM, et al. Gastroenterology. 2017 Oct;153(4):936-947. doi: 10.1053/j.gastro.2017.06.010. Epub 2017 Jun 15. Gastroenterology. 2017. PMID: 28625832 Clinical Trial.
1,545 results